Board of Directors of the Foundation for Biomedical Research

Claire PomeroyClaire Pomeroy, MD, MBA—president, Albert and Mary Lasker Foundation, chair of the Board of Directors of the Foundation for Biomedical Research

At the Lasker Foundation, Dr. Pomeroy oversees the Lasker Awards program, as well as education and outreach initiatives with the mission of increasing support for biomedical research. An expert in infectious diseases, Dr. Pomeroy is a long-time advocate for public health and patients, especially those with HIV/AIDS. She serves on the boards of Becton Dickinson and Company, New York Academy of Medicine, Sierra Health Foundation and New York Blood Center, and is a trustee for Morehouse School of Medicine.
James AllanJames Allan, MD—co-director of the Cardiothoracic Transplantation Lab at Massachusetts General Hospital; president of the American Society of Transplantation

Dr. Allan is a thoracic surgeon whose clinical interests include the surgical management of benign and malignant diseases of the lungs and esophagus. His research interests involve transplantation tolerance and xenotransplantation as studied in large animal models.
Lenore CooneyLenore Cooney—communications consultant at LCooney Consulting

Ms. Cooney’s present and former consultancy practices have served the strategic communications needs of clients in health care, disease prevention, nutrition, pharmaceuticals, biotechnology, and health advocacy in the U.S. and internationally. She has also managed educational and product marketing projects in health and medicine.
Henry FriedmanHenry S. Friedman, MD—James P. Powell, Jr. Professor of Pediatric Oncology; professor of neurosurgery; assistant professor of pathology; associate professor of medicine; professor of pediatrics at Duke University School of Medicine

Dr. Friedman is an academic adult and pediatric neuro-oncologist who helps to lead The Preston Robert Tisch Brain Tumor Center at Duke University. The author of more than 500 peer-reviewed articles, reviews, and book chapters, Dr. Friedman’s laboratory work involves the study of adult and child central nervous system malignancies with athymic nude mice and rats.
James GreenwoodJames Greenwood—president, Biotechnology Industry Orgnaization (BIO)

Mr. Greenwood is president and CEO of Biotechnology Industry Organization (BIO), which represents more than 1,200 U.S. and internationally-based biotechnology companies, academic institutions, state biotech centers, and related organizations. BIO members are involved in research and development of healthcare, agricultural, industrial, and environmental biotechnology products.
Elton GreigElton Greig—director, corporate affairs at Amgen

Mr. Greig is responsible for enterprise and executive communications. He supports the CEO's internal and external communications, including the development and refinement of key messages, talking points and presentations.
Atul GroverAtul Grover, MD, PhD—executive vice president, Association of American Medical Colleges (AAMC)

At AAMC, Dr. Grover provides strategic leadership in the areas of medical education, academic affairs, health care affairs, scientific affairs, learning and leadership programming, diversity and inclusion, public policy, and communications. Dr. Grover holds faculty appointments at the George Washington University (GWU) School of Medicine, where he earned his MD, and at the Johns Hopkins University Bloomberg School of Public Health, where he earned his PhD.
David KornDavid Korn, MD—(B.A., scl, M.D., cl, Harvard University) is Consultant in Pathology at the Massachusetts General Hospital and Professor of Pathology at Harvard Medical School.

From November 15, 2008 to June 30, 2011, Dr. Korn was the inaugural Vice-Provost for Research at Harvard University. Prior to joining Harvard, Dr. Korn had served as the Chief Scientific Officer of the Association of American Medical Colleges (AAMC) in Washington, D.C. since January 15, 2007, and before that as the Senior Vice President for Biomedical and Health Sciences Research at the Association since September 1, 1997. Dr. Korn served as Carl and Elizabeth Naumann Professor and Dean of the Stanford University School of Medicine from October 1984 to April 1995, and as Vice President of Stanford University from January 1986 to April 1995. Previously, he had served as Professor and Founding Chairman of the Department of Pathology at Stanford, and Chief of the Pathology Service at the Stanford University Hospital, since June 1968. Dr. Korn has been Chairman of the Stanford University Committee on Research; President of the American Association of Pathologists (now the American Society for Investigative Pathology), from which he received the Gold-Headed Cane Award for lifetime achievement in 2004; President of the Association of Pathology Chairman, from which he received the Distinguished Service Award in 1999; a member of the Board of Directors and of the Executive Committee of the Federation of American Societies for Experimental Biology; and a member of the Board of Directors of the Association of Academic Health Centers. Dr. Korn was a founder and Chairman of the Board of Directors of the California Transplant Donor Network, one of the nation’s largest Organ Procurement Organizations. Later, he was a founder of the nonprofit Association for the Accreditation of Human Research Protection Programs, created to enhance and standardize the protection of human research participants. He has been a member of the Institute of Medicine of the National Academies of Science since 1989, and has served on many NAS and IOM committees. He was a founder of the IOM’s Clinical Research Roundtable; a member of the Executive Committee of the NAS Committee on Science, Technology and Law from its inception in 2000 and co-chairman from 2010-2014; and he is currently on the NAS Committee on Science, Engineering, Medicine, and Public Policy. In 1996-97 Dr. Korn chaired a Special Subcommittee of the Science Board of the Food and Drug Administration to Review the FDA’s Intramural Research Program, for which he received the Commissioner’s Special Citation and the Harvey W. Wiley Medal. From 1984 to 1991 he served as Chairman of the National Cancer Advisory Board, a position to which he was appointed by President Reagan. Dr. Korn is a Fellow of the AAAS and has served on its Council, and he was a member of the University Grants Committee of Hong Kong from 1998-2004, where he was Chairman of the Medical Subcommittee. Dr. Korn served on the Boards of Directors of the Stanford University Hospital from October 1982 to April 1995, the Children’s Hospital at Stanford from October 1984 to its closure, and the Lucile Salter Packard Children’s Hospital at Stanford from October 1984 to April 1995. He was a member of the Board of Directors of the California Society of Pathologists from 1983-86. Dr. Korn has been a member of the editorial boards of the American Journal of Pathology, The Journal of Biological Chemistry, and Human Pathology, and for many years was an Associate Editor of the latter. He has served on many Society Councils and Boards. His more than160 publications range from bacteriophage biochemistry and genetics to the biochemistry and molecular biology of DNA replication in human cells, and more recently, focus on issues of academic values and integrity, research integrity, health and science policy, and financial conflicts of interest in academic medicine.
Joanne KurtzbergJoanne Kurtzberg, MD—chief scientific officer, Robertson Clinical and Translational Cell Therapy Program; Jerome S. Harris Professor of Pediatrics at Duke University Medical Center

Dr. Kurtzberg expert in pediatric hematology/oncology, pediatric blood and marrow transplantation, umbilical cord blood banking and transplantation, and novel applications of cord blood in the emerging fields of cellular therapies and regenerative medicine. She has published more than 300 peer-reviewed papers, chapters, and scientific reviews.
Michael LairmoreMichael Lairmore, DVM, PhD—dean and distinguished professor, School of Veterinary Medicine at the University of California, Davis

Dr. Lairmore presides over the William R. Pritchard Veterinary Medical Teaching Hospital, the California Animal Health and Food Safety Laboratory System, the Veterinary Medicine Teaching and Research Center, Veterinary Medicine Extension, and other centers of excellence. Dr. Lairmore is a member of the National Academy of Medicine; a fellow at AAAS; and a fellow at the American Academia of Microbiology. He has authored or co-authored more than 175 scientific publications. His research has provided significant breakthroughs in the biology of the human retroviruses and the understanding of viral-associated carcinogenesis.
John NeiderhuberJohn E. Niederhuber, MD—CEO, Inova Health System, Inova Translational Medicine Institute

As founder and leader of the ITMI, Dr. Niederhuber directs a program that integrates technical innovation, informatics, and sophisticated genomic analyses with the goal of managing disease risk and delivering excellence in individualized (personalized) healthcare, research, and education. He was formerly the director of the National Cancer Institute.
Arthur RubensteinArthur H. Rubenstein, MBBCh—professor of medicine, Raymond and Ruth Perelman School of Medicine at the University of Pennsylvania

Dr. Rubenstein is an endocrinologist recognized for clinical expertise and groundbreaking research in diabetes. He was previously dean of the University of Pennsylvania Health System. Dr. Rubenstein has authored more than 350 publications, served in editorial advisory positions for academic journals, and chaired numerous national scientific and medical organizations.
Carol SchemanCarol Scheman, MSSA—independent non-profit organization management professional

As an independent consultant, Ms. Scheman has worked with the federal government, research universities, and scientific societies. She previously was vice president of the Association of American Universities and was the first woman appointed deputy commissioner of the Food and Drug Administration (FDA).
Oswald StewardOswald Steward, PhD—director, Reeve-Irvine Research Center for Spinal Cord Injury; senior associate dean for research; professor of neurobiology and behavior, University of California, Irvine School of Medicine

Dr. Steward is known for his research on how nerve cells create and maintain their connections with each other, and how these synapses are modified after injury. He has also conducted research on how genes influence nerve cell regeneration, growth and function, and how physiological activity affects nerve cell connections.
Andrew WarshawAndrew L. Warshaw, MD, FACS, FRCSEd— W. Gerald Austen Professor of Surgery, Harvard Medical School; surgeon-in-chief, chairman, emeritus, Department of Surgery at Massachusetts General Hospital, director, Andrew L. Warshaw, MD, Institute for Pancreatic Cancer

Dr. Warshaw is an eminent researcher and surgeon who has made important contributions in the study of pancreatic cancer. His bibliography lists 385 original reports as well as 250 book chapters, reviews, and monographs and 13 books. The editor-in-chief of the journal SURGERY. Dr. Warshaw has also served as president of numerous national scientific and medical organizations.



Board of Advisors of the Foundation for Biomedical Research

Irv WeissmanIrv Weissman, MD—director, Ludwig Center for Stem Cell Research; Virginia and D.K. Ludwig Professor for Clinical Investigation in Cancer Research at Stanford University

Dr. Weissman is an expert in the fields of hematopoiesis, leukemia, and hematopoietic stem cells (HSC). His laboratory, the first to identify and isolate the blood-forming stem cell (HSC) from mice, is also distinguished for the discovery of the human HSC, a human brain-forming stem cell population, as well as skeletal muscle stem cells and an osteochondral stem cell in mice.
Elias ZerhouniElias Zerhouni, MD—president, global research and development, Sanofi; professor of radiology and biomedical engineering, Johns Hopkins University and Hospital

Dr. Zerhouni is an Algerian-born American physician, scientist, radiologist, inventor, entrepreneur, and biomedical engineer. He was appointed director of the National Institutes of Health in 2002, and is currently a senior fellow of the Bill and Melinda Gates Foundations. Dr. Zerhouni authored more than 200 publications, holds eight patents, and has founded or co-founded 5 start-up companies.